Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Novavax (Nasdaq: NVAX) will report fourth quarter and full year 2025 financial results and operational highlights on February 26, 2026 at 8:30 a.m. ET.
Rhea-AI Summary
Novavax (Nasdaq: NVAX) will report fourth quarter and full year 2025 financial results and operational highlights on February 26, 2026 at 8:30 a.m. ET.
Investors may join the live conference call by registering for an automated call back or by dialing in; a replay and webcast will be available after the event.
Positive
- None.
Negative
- None.
Details
News Market Reaction – NVAX
On Feb 19, the day this news came out, NVAX closed 6.16% above the previous close.
Data tracked by StockTitan Argus for the Feb 19 session.
Key Figures
- Earnings call date
- February 26, 2026
- Scheduled fourth quarter and full year 2025 results
- Earnings call time
- 8:30 a.m. ET
- Start time for conference call on financial results
- Replay start time
- 11:30 a.m. ET, February 26, 2026
- Beginning of earnings call replay availability
- Replay end date (phone)
- 11:59 p.m. ET, March 5, 2026
- End of telephone replay availability
- Replay end date (webcast)
- March 25, 2026
- End of webcast replay availability at ir.novavax.com/events
- U.S. dial-in
- (888) 880-3330
- U.S. dial-in number for live conference call
- International dial-in
- (+1) (646) 357-8766
- International dial-in number for live conference call
- Replay passcode
- 9610065#
- Required passcode for telephone replay access
Historical Context
-
Pfizer license for Matrix‑M with upfront and milestone payments.
-
Participation in 44th J.P. Morgan Healthcare Conference with webcast.
-
Jefferies London Healthcare Conference fireside chat announcement.
-
Q3 2025 results with $70M revenue and $202M net loss.
-
Completion of U.S. marketing authorization transfer to Sanofi with $25M milestone.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference call details: | |
Date: | February 26, 2026 |
Time: | 8:30 a.m. ET |
URL to register phone: | |
Dial-in number: | (888) 880-3330 ( |
(+1) (646) 357-8766 (International) | |
Webcast: | |
- Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.
- Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call.
- To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled start time.
Replay details: | |
Date: | Available starting at 11:30 a.m. ET, February 26, 2026, until 11:59 p.m. ET, March 5, 2026 |
Dial-in number: | (800) 770-2030 ( |
(+1) (609) 800-9909 (International) | |
Passcode: | 9610065# |
Webcast: | ir.novavax.com/events, until March 25, 2026 |
About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M® adjuvant and protein-based nanoparticles. The Company's growth strategy focuses on maximizing the impact of its cutting-edge technology by forging strategic partnerships for its Matrix-M adjuvant and R&D assets. Please visit novavax.com and LinkedIn for more information.
Contacts:
Investors
Luis Sanay, CFA
240-268-2022
ir@novavax.com
Media
Yvonne Sprow
844-264-8571
media@novavax.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026-302692051.html
SOURCE Novavax, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.